SN
Sahil Noorani
About Sahil Noorani
Sahil Noorani has 5 years in corporate governance. Holds Director and Designated Partner roles. Currently with 7 companies, including Zeroharm Sciences Private Limited and Fairmount S Metro Spaces Llp. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Zeroharm Sciences Private Limited
U24100TG2020PTC145072
|
Director | 05 Jun 2021 | 2020 | Active |
Fairmount S Metro Spaces Llp
ACU-9137
|
Designated Partner | 01 Feb 2026 | 2026 | Active |
|
Fairmount And Friends Llp
ACN-4841
|
Designated Partner | 09 Apr 2025 | 2025 | Active |
|
Fairmount Dreams Llp
ACN-4856
|
Designated Partner | 09 Apr 2025 | 2025 | Active |
|
Fairmount Golden Mile Private Limited
U45202TG2019PTC136270
|
Director | 03 Dec 2024 | 2019 | Active |
|
Fairmount Technology Solutions Llp
ACB-6310
|
Partner | 12 Jun 2023 | 2023 | Active |
|
Fairmount Builders Llp
ACA-2204
|
Designated Partner | 02 Mar 2023 | 2023 | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sahil Noorani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sahil Noorani
Sahil Noorani has 5 years in corporate governance. Holds Director and Designated Partner roles. Currently with 7 companies, including Zeroharm Sciences Private Limited and Fairmount S Metro Spaces Llp. Engaged in General Business, Technology. Contributes to corporate operations.
Sahil Noorani is associated with 7 companies as Director and Designated Partner.
Sahil Noorani has expertise in General Business, Technology.
Sahil Noorani has 5 years in corporate governance.